Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Fred M. Gordin"'
Autor:
Kate Buchacz PhD, Jennifer Farrior MS, Geetha Beauchamp MS, Laura McKinstry MPH, Ann E. Kurth CNM, PhD, Barry S. Zingman MD, Fred M. Gordin MD, Deborah Donnell PhD, Kenneth H. Mayer MD, Wafaa M. El-Sadr MD, MPH, Bernard Branson MD
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 16 (2017)
As part of the HPTN 065 study in the Bronx, New York and Washington, the authors, we surveyed clinicians to assess for shifts in their practices and attitudes around HIV treatment and prevention. Antiretroviral therapy (ART)-prescribing clinicians at
Externí odkaz:
https://doaj.org/article/5c5ddc618a1f4860b644480ef19b4fff
Autor:
Kristen M. Kreisel, J. Kristie Johnson, O. Colin Stine, Michelle D. Shardell, Eli N. Perencevich, Alan J. Lesse, Fred M. Gordin, Michael W. Climo, Mary-Claire Roghmann
Publikováno v:
Emerging Infectious Diseases, Vol 16, Iss 9, Pp 1419-1427 (2010)
To assess the association of illicit drug use and USA300 methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, a multicenter study was conducted at 4 Veterans Affairs medical centers during 2004–2008. The study showed that users of illicit
Externí odkaz:
https://doaj.org/article/8ebe89274dc249b386ee9019ede6ea33
Autor:
Stuart Johnson, Dale N. Gerding, Xue Li, Domenic J. Reda, Curtis J. Donskey, Kalpana Gupta, Matthew Bidwell Goetz, Michael W. Climo, Fred M. Gordin, Robert Ringer, Neil Johnson, Michelle Johnson, Lawrence A. Calais, Alexa M. Goldberg, Ling Ge, Tamara Haegerich
Publikováno v:
Contemporary clinical trials. 116
BackgroundAlthough many large, randomized controlled trials (RCT) have been conducted on antibiotic therapy for patients with primary C. difficile infections (CDI), few RCTs have been performed for patients with recurrent CDI (rCDI). In addition, fec
Autor:
Sonja M Bjerk, Jason V Baker, Sean Emery, Jacqueline Neuhaus, Brian Angus, Fred M Gordin, Sarah L Pett, Christoph Stephan, Ken M Kunisaki, INSIGHT SMART Study Group
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56249 (2013)
Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do not cur
Externí odkaz:
https://doaj.org/article/fbe5d860df0048e6bff1e052667a3f2b
Autor:
Richard T. Davey, Jens D Lundgren, Fred M. Gordin, Norman Markowitz, Henry Clifford Lane, Sarah Pett, Paul F. Riska, Eduardo Fernandez-Cruz, John Beigel, Zelalem Temesgen, Virginia Kan, Deborah Wentworth, Mark N. Polizzotto, Nicole Engen, Mamta K Jain, Abdel Babiker, Surender Khurana, Kiat Ruxrungtham, James D. Neaton
Publikováno v:
SSRN Electronic Journal.
Background: Despite treatment with licensed antiviral agents, high rates of influenza-related morbidity and mortality occur worldwide. Methods: Adults hospitalized with laboratory-confirmed influenza were randomized (1:1) to a single double-blind inf
Autor:
Alberto La Rosa, M. Elsa Villarino, Timothy R. Sterling, Guilherme Amaral Calvet, Nigel A. Scott, Michael P. Chen, Richard E. Chaisson, Rosa M Infante, José M. Miró, Constance A. Benson, Debra Benator, Fred M. Gordin
Publikováno v:
AIDS. 30:1607-1615
OBJECTIVE Compare the effectiveness, tolerability, and safety of 3 months of weekly rifapentine and isoniazid under direct observation (3HP) versus 9 months of daily isoniazid (9H) in HIV-infected persons. DESIGN Prospective, randomized, and open-lab
Autor:
Jacqueline Neuhaus, Gail V. Matthews, Juergen K. Rockstroh, Jose Hidalgo, Rui Sarmento-Castro, Lars Peters, Fred M. Gordin, Sean Emery, Christoph Stephan, Nagalingeswaran Kumarasamy, Nila J. Dharan, Kristen M. Marks, Alejandro Arenas-Pinto, Carol Emerson
Publikováno v:
Hepatology (Baltimore, Md.)
The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the Strategic Timing of AntiRetroviral Treatment (START) trial for live
Autor:
Shweta Sharma, Marcelo Wolff, Fred M. Gordin, Sean Emery, Mauro Schechter, E. Bakowska, J. N. Neaton, Abdel Babiker, M. J. Wiselka, Jens D Lundgren
Publikováno v:
HIV Medicine. 16:30-36
Objectives: The risks and benefits of initiating antiretroviral treatment (ART) at high CD4 cell counts have not been reliably quantified. The Strategic Timing of AntiRetroviral Treatment (START) study is a randomized international clinical trial tha
Autor:
Athanasios Skoutelis, Matthew Law, Birgit Grund, Jens D Lundgren, James D. Neaton, Thomas Benfield, Ian Williams, David Munroe, M. H. Losso, Martin Wiselka, Noluthando Mwelase, Mauro Schechter, Ernest Ekong, Fred M. Gordin, Jean-Michel Molina, Linos Vandekerckhove
Publikováno v:
Lancet HIV
Summary Background Immediate initiation of antiretroviral therapy (ART) in asymptomatic adults with CD4 counts higher than 500 cells per μL, as recommended, might not always be possible in resource-limited settings. We aimed to identify subgroups of
Autor:
Michael Kharfen, Lucia V. Torian, Barry S. Zingman, Richard Elion, Wafaa El-Sadr, Theresa Gamble, Garret Lum, H. Irene Hall, Jason Leider, Vanessa Elharrar, Deborah Donnell, David N. Burns, Bernard M. Branson, Geetha Beauchamp, Fred M. Gordin, Allison Zerbe
Publikováno v:
JAMA internal medicine. 177(8)
Achieving linkage to care and viral suppression in human immunodeficiency virus (HIV)-positive patients improves their well-being and prevents new infections. Current gaps in the HIV care continuum substantially limit such benefits.To evaluate the ef